Worldwide Coronavirus Disease 2019 (COVID-19) epidemic makes the management of acute myocardial infarction (AMI) more complicated, effective treatment without further dissemination is thus quite challenging. Recently, we successfully treated three representative AMI cases, by sharing these detailed procedures, we summarized some important issues including patient screening, reperfusion strategy selecting, personnel/catheter lab protection principle, as well as operation tactics, which may lend precious experience on AMI treating during the ongoing COVID-19 pandemic situation.
第一作者单位：[1]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Cardiol, Wuhan, Peoples R China
通讯作者：
通讯机构：[1]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Cardiol, Wuhan, Peoples R China[*1]Tongji Hosp, Dept Cardiol, Jiefang Ave, Wuhan 430030, Peoples R China
推荐引用方式(GB/T 7714)：
Xiao Zhichao,Xu Chang,Wang Daowen,et al.The experience of treating patients with acute myocardial infarction under the COVID-19 epidemic[J].CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS.2021,97(2):E244-E248.doi:10.1002/ccd.28951.
APA：
Xiao, Zhichao,Xu, Chang,Wang, Daowen&Zeng, Hesong.(2021).The experience of treating patients with acute myocardial infarction under the COVID-19 epidemic.CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS,97,(2)
MLA：
Xiao, Zhichao,et al."The experience of treating patients with acute myocardial infarction under the COVID-19 epidemic".CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS 97..2(2021):E244-E248
